BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38131633)

  • 1. Serum remnant cholesterol is a potential predictor of liver stiffness in patients with nonalcoholic fatty liver disease.
    Wang Y; Song W; Yuan Q; Mai M; Luo M; Fan J; Zhang P; Guo H
    Scand J Gastroenterol; 2024 Apr; 59(4):469-479. PubMed ID: 38131633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of remnant cholesterol with nonalcoholic fatty liver disease: a general population-based study.
    Zou Y; Lan J; Zhong Y; Yang S; Zhang H; Xie G
    Lipids Health Dis; 2021 Oct; 20(1):139. PubMed ID: 34657611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of traditional and non-traditional lipid indicators in the diagnosis of nonalcoholic fatty liver disease in a Japanese population.
    Lu S; Kuang M; Yue J; Hu C; Sheng G; Zou Y
    Lipids Health Dis; 2022 Oct; 21(1):95. PubMed ID: 36207744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between remnant cholesterol and insulin resistance levels in patients with metabolic-associated fatty liver disease.
    Wang S; Zhang Q; Qin B
    Sci Rep; 2024 Feb; 14(1):4596. PubMed ID: 38409335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the mediating role of BMI in associations of different folate forms with hepatic steatosis and liver fibrosis in adolescents in the USA: results from the NHANES 2017-2018.
    Wen J; Fei Y; Yuan L; Li K; Xu Q; Cao X; Su J; Zhu Y; Zhang Z
    Front Endocrinol (Lausanne); 2023; 14():1273580. PubMed ID: 38116318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive Role of Neutrophil-Percentage-to-Albumin Ratio (NPAR) in Nonalcoholic Fatty Liver Disease and Advanced Liver Fibrosis in Nondiabetic US Adults: Evidence from NHANES 2017-2018.
    Liu CF; Chien LW
    Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of serum vitamin C with liver fibrosis in adults with nonalcoholic fatty liver disease.
    Zhao Y; Li H
    Scand J Gastroenterol; 2022 Jul; 57(7):872-877. PubMed ID: 35189786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remnant cholesterol has a non-linear association with non-alcoholic fatty liver disease.
    Chen J; Su Y; Su X; Luo F
    Diabetes Res Clin Pract; 2023 Jul; 201():110733. PubMed ID: 37245725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher serum uric acid to HDL-cholesterol ratio is associated with onset of non-alcoholic fatty liver disease in a non-obese Chinese population with normal blood lipid levels.
    Zhu W; Liang A; Shi P; Yuan S; Zhu Y; Fu J; Zheng T; Wen Z; Wu X
    BMC Gastroenterol; 2022 Apr; 22(1):196. PubMed ID: 35448944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remnant cholesterol/high-density lipoprotein cholesterol ratio is a new powerful tool for identifying non-alcoholic fatty liver disease.
    Zou Y; Hu C; Kuang M; Chai Y
    BMC Gastroenterol; 2022 Mar; 22(1):134. PubMed ID: 35331166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Circulating Serum miR-34a and miR-122 with Dyslipidemia among Patients with Non-Alcoholic Fatty Liver Disease.
    Salvoza NC; Klinzing DC; Gopez-Cervantes J; Baclig MO
    PLoS One; 2016; 11(4):e0153497. PubMed ID: 27077736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease.
    Lee HW; Kim BK; Kim SU; Park JY; Kim DY; Ahn SH; Kim KJ; Han KH
    Dig Dis Sci; 2017 Aug; 62(8):2150-2158. PubMed ID: 28523578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between the platelet/high-density lipoprotein cholesterol ratio and nonalcoholic fatty liver disease: results from NHANES 2017-2020.
    Lu CF; Cang XM; Liu WS; Wang LH; Huang HY; Sang SM; Wang XQ; Fang XX; Xu F
    Lipids Health Dis; 2023 Aug; 22(1):130. PubMed ID: 37568178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triglyceride glucose-waist circumference: the optimum index to screen nonalcoholic fatty liver disease in non-obese adults.
    Li S; Feng L; Ding J; Zhou W; Yuan T; Mao J
    BMC Gastroenterol; 2023 Nov; 23(1):376. PubMed ID: 37919650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Lipid Abnormalities and Nonalcoholic Fatty Liver Disease in Adult Males.
    Peng K; Mo Z; Tian G
    Am J Med Sci; 2017 Mar; 353(3):236-241. PubMed ID: 28262209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum vitamin D is associated with ultrasound-defined hepatic fibrosis.
    Jiang R; Zhou Y; Han L; Hong Z
    Clin Res Hepatol Gastroenterol; 2023 Dec; 47(10):102228. PubMed ID: 37865224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of serum uric acid levels and anthropometric parameters with non-alcoholic fatty liver disease in healthy individuals: innovative insights from a cross-sectional study.
    Aydin A; Goktas Aydin S
    Curr Med Res Opin; 2024 Feb; 40(2):209-215. PubMed ID: 38111962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Combination of Remnant Cholesterol and Waist Circumference Offers Predictive Value for Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study from a Medical Examination Center.
    Jia Z; Pan X; Chen S
    Diabetes Metab Syndr Obes; 2023; 16():3459-3469. PubMed ID: 37937236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The triglyceride-glucose index is associated with the severity of hepatic steatosis and the presence of liver fibrosis in non-alcoholic fatty liver disease: a cross-sectional study in Chinese adults.
    Guo W; Lu J; Qin P; Li X; Zhu W; Wu J; Xu N; Zhang Q
    Lipids Health Dis; 2020 Oct; 19(1):218. PubMed ID: 33028338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum cytokeratin-18 and its relation to liver fibrosis and steatosis diagnosed by FibroScan and controlled attenuation parameter in nonalcoholic fatty liver disease and hepatitis C virus patients.
    Darweesh SK; AbdElAziz RA; Abd-ElFatah DS; AbdElazim NA; Fathi SA; Attia D; AbdAllah M
    Eur J Gastroenterol Hepatol; 2019 May; 31(5):633-641. PubMed ID: 30839434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.